Literature DB >> 7530024

Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure.

D Bizub-Bender1, J Kulkosky, A M Skalka.   

Abstract

Eleven murine hybridoma clones were selected for their ability to produce anti-HIV-1 integrase (IN) antibodies. Competition and epitope mapping studies allowed segregation of the monoclonal antibodies (MAbs) into four distinct classes. The five MAbs that comprise the first class showed high affinity for epitopes within an N-terminal domain of 58 amino acids that includes a conserved zinc finger motif. The second class, with two MAbs, showed high affinity for epitopes within 29 amino acids at the C terminus. Another two MAbs, which constitute the third class, displayed moderate affinities for epitopes that mapped to regions within the highly conserved catalytic core referred to as the D,D(35)E domain. One of these MAbs showed significant cross-reactivity with HIV-2 IN and weak, but detectable, cross-reactivity with RSV IN. The remaining two MAbs, which comprise the fourth class, exhibited fairly low binding affinities and appeared to recognize epitopes in the zinc finger motif domain as well as the C-terminal half of the IN protein. The MAbs can be used for immunoprecipitation and immunoblotting procedures as well as for purification of HIV-1 IN protein by affinity chromatography. We show that several can also be used to immunostain viral IN sequences in HIV-1-infected T cells, presumably as a component of Gag-Pol precursors. Finally, analysis of our mapping and competition data suggests a structure for mature IN in which the C terminus approaches the central core domain, and the N and C termini touch or are proximal to each other. These MAbs should prove useful for further analyses of the structure and function of IN both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530024     DOI: 10.1089/aid.1994.10.1105

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

1.  Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase.

Authors:  T Ishikawa; N Okui; N Kobayashi; R Sakuma; T Kitamura; Y Kitamura
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.

Authors:  Iris Oz; Orna Avidan; Amnon Hizi
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.

Authors:  S Paul; L M Breuninger; K D Tew; H Shen; G D Kruh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Functional analysis of N-terminal residues of ty1 integrase.

Authors:  Sharon P Moore; David J Garfinkel
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

5.  Refined solution structure of the dimeric N-terminal HHCC domain of HIV-2 integrase.

Authors:  A P Eijkelenboom; F M van den Ent; R Wechselberger; R H Plasterk; R Kaptein; R Boelens
Journal:  J Biomol NMR       Date:  2000-10       Impact factor: 2.835

6.  Monoclonal antibodies against human immunodeficiency virus type 1 integrase: epitope mapping and differential effects on integrase activities in vitro.

Authors:  B M Nilsen; I R Haugan; K Berg; L Olsen; P O Brown; D E Helland
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Monoclonal antibodies against Rous sarcoma virus integrase protein exert differential effects on integrase function in vitro.

Authors:  B Müller; D Bizub-Bender; M D Andrake; K S Jones; A M Skalka
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.

Authors:  E Tse; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

9.  Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

10.  Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases.

Authors:  G Kukolj; K S Jones; A M Skalka
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.